{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:24:37Z","timestamp":1787009077367,"version":"build-2736575974"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T00:00:00Z","timestamp":1728518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"NIGMS","doi-asserted-by":"publisher","award":["P20GM103643"],"award-info":[{"award-number":["P20GM103643"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"name":"MEGA"},{"name":"RAPID","award":["A22-0392 NYUCD"],"award-info":[{"award-number":["A22-0392 NYUCD"]}]},{"name":"Department of Molecular Pathobiology Accelerator","award":["RB841-001421"],"award-info":[{"award-number":["RB841-001421"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["B01 (2024)"],"award-info":[{"award-number":["B01 (2024)"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG056397"],"award-info":[{"award-number":["R01AG056397"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Canagliflozin (CANA) is a sodium glucose cotransporter-2 inhibitor that reduces blood glucose levels. Sodium glucose cotransporter-2 is primarily expressed in the kidney, but not in any bone cells, therefore effects on the skeleton are likely to be non-cell autonomous. Originally developed to treat type II diabetes, CANA use has expanded to treat cardiovascular and renovascular disease. Clinical trials examining CANA in diabetic patients have produced contradictory reports on fracture risk, but there are limited data of CANA in nondiabetic conditions. In nondiabetic preclinical models, short-term treatment with CANA negatively affected trabecular bone whereas long-term treatment reduced cortical bone mineralization in male but not female mice. To investigate the skeletal effects of an intermediate period of CANA treatment, we treated male and female C57BL\/6\u00a0J mice with CANA (180\u00a0ppm) for 6\u00a0months. Age at treatment initiation was also evaluated, with cohorts starting CANA prior to skeletal maturity (3-months-old) or in adulthood (6-months-old). Longitudinal assessments of bone mineral density revealed early benefits of CANA treatment in female mice. At euthanasia, both trabecular and cortical bone morphology were improved by CANA treatment in males and females. Bone formation was reduced at the endosteal surface. CANA decreased osteoblast number in male mice and bone marrow adiposity in females. Overall, more skeletal benefits were recorded in CANA-treated females than males. Urinary calcium output increased with CANA treatment, but parathyroid hormone was not changed. Despite reduced fasting blood glucose, body composition and whole-body metabolism were minimally changed by CANA treatment. For all outcome measures, limited differences were recorded based on age at treatment initiation. This study demonstrated that in nondiabetic C57BL\/6\u00a0J mice, an intermediate period of CANA treatment improved bone morphology, but reduced osteoblast and bone marrow adipocyte number as well as serum procollagen type 1\u00a0N-terminal pro-peptide in a sex-specific manner.<\/jats:p>","DOI":"10.1093\/jbmrpl\/ziae128","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T23:30:10Z","timestamp":1728084610000},"source":"Crossref","is-referenced-by-count":5,"title":["In nondiabetic C57BL\/6J mice, canagliflozin affects the skeleton in a sex- and age-dependent manner"],"prefix":"10.1093","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4782-3912","authenticated-orcid":false,"given":"Carolyn","family":"Chlebek","sequence":"first","affiliation":[{"name":"Center for Molecular Medicine, MaineHealth Institute for Research , Scarborough, ME 04074 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey","family":"McAndrews","sequence":"additional","affiliation":[{"name":"University of New England College of Osteopathic Medicine , Biddeford, ME 04005 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha N","family":"Costa","sequence":"additional","affiliation":[{"name":"Center for Molecular Medicine, MaineHealth Institute for Research , Scarborough, ME 04074 ,","place":["United States"]},{"name":"Graduate School of Biomedical Sciences and Engineering, University of Maine , Orono, ME 04469 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria E","family":"DeMambro","sequence":"additional","affiliation":[{"name":"Center for Molecular Medicine, MaineHealth Institute for Research , Scarborough, ME 04074 ,","place":["United States"]},{"name":"Graduate School of Biomedical Sciences and Engineering, University of Maine , Orono, ME 04469 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoshana","family":"Yakar","sequence":"additional","affiliation":[{"name":"New York University College of Dentistry , New York, NY 10010 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford J","family":"Rosen","sequence":"additional","affiliation":[{"name":"Center for Molecular Medicine, MaineHealth Institute for Research , Scarborough, ME 04074 ,","place":["United States"]},{"name":"Graduate School of Biomedical Sciences and Engineering, University of Maine , Orono, ME 04469 ,","place":["United States"]},{"name":"Tufts University School of Medicine, Tufts University , 136 Harrison Avenue, Boston, MA 02111 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,10,10]]},"reference":[{"issue":"1","key":"2024110806311245900_ref1","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1681\/ASN.2010030246","article-title":"SGLT2 mediates glucose reabsorption in the early proximal tubule","volume":"22","author":"Vallon","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"2024110806311245900_ref2","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1007\/s00125-019-4955-5","article-title":"Canagliflozin and fracture risk in individuals with type 2 diabetes: results from the CANVAS program","volume":"62","author":"Zhou","year":"2019","journal-title":"Diabetologia"},{"issue":"7","key":"2024110806311245900_ref3","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"issue":"4","key":"2024110806311245900_ref4","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/s41591-022-01703-8","article-title":"The SGLT2 inhibitor canagliflozin in heart failure: the CHIEF-HF remote, patient-centered randomized trial","volume":"28","author":"Spertus","year":"2022","journal-title":"Nat Med"},{"issue":"9","key":"2024110806311245900_ref5","doi-asserted-by":"publisher","first-page":"e023811","DOI":"10.1161\/JAHA.121.023811","article-title":"National trends in use of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists by cardiologists and other specialties, 2015 to 2020","volume":"11","author":"Adhikari","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"21","key":"2024110806311245900_ref6","doi-asserted-by":"publisher","first-page":"e140019","DOI":"10.1172\/jci.insight.140019","article-title":"Canagliflozin extends life span in genetically heterogeneous male but not female mice","volume":"5","author":"Miller","year":"2020","journal-title":"JCI Insight"},{"issue":"4","key":"2024110806311245900_ref7","doi-asserted-by":"publisher","first-page":"921","DOI":"10.2337\/dc19-1943","article-title":"Trends in clinical characteristics and prescribing preferences for SGLT2 inhibitors and GLP-1 receptor agonists, 2013\u20132018","volume":"43","author":"Dave","year":"2020","journal-title":"Diabetes Care"},{"issue":"10","key":"2024110806311245900_ref8","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1093\/gerona\/glt071","article-title":"Age- and menopause-related bone loss compromise cortical and trabecular microstructure","volume":"68","author":"Seeman","year":"2013","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"2024110806311245900_ref9","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1210\/jc.2015-3167","article-title":"Effects of canagliflozin on fracture risk in patients with type 2 diabetes mellitus","volume":"101","author":"Watts","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2024110806311245900_ref10","doi-asserted-by":"publisher","first-page":"e2335797","DOI":"10.1001\/jamanetworkopen.2023.35797","article-title":"Sodium-glucose cotransporter 2 inhibitors vs Incretin-based drugs and risk of fractures for type 2 diabetes","volume":"6","author":"Ko","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"10","key":"2024110806311245900_ref11","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1111\/dom.15193","article-title":"Safety of sodium-glucose cotransporter 2 inhibitors in elderly patients with type 2 diabetes: a meta-analysis of randomized controlled trials","volume":"25","author":"Rigato","year":"2023","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"2024110806311245900_ref12","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00228-024-03631-7","article-title":"The relationship between use of SGLT2is and incidence of respiratory and infectious diseases and site-specific fractures: a meta-analysis based on 32 large RCTs","volume":"80","author":"Wang","year":"2024","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"2024110806311245900_ref13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s13300-010-0006-4","article-title":"Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family members","volume":"1","author":"Chen","year":"2010","journal-title":"Diabetes Ther"},{"issue":"11","key":"2024110806311245900_ref14","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1002\/jbmr.4686","article-title":"Molecular identification of spatially distinct anabolic responses to mechanical loading in murine cortical bone","volume":"37","author":"Chlebek","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2024110806311245900_ref15","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/jbm4.10117","article-title":"Rethinking bone disease in kidney disease","volume":"2","author":"Damasiewicz","year":"2018","journal-title":"JBMR Plus"},{"issue":"6","key":"2024110806311245900_ref16","doi-asserted-by":"publisher","first-page":"F998","DOI":"10.1152\/ajprenal.00032.2017","article-title":"Effect of diuretics on renal tubular transport of calcium and magnesium","volume":"312","author":"Alexander","year":"2017","journal-title":"Am J Physiol-Ren Physiol"},{"issue":"1","key":"2024110806311245900_ref17","doi-asserted-by":"publisher","first-page":"e13959","DOI":"10.1111\/apha.13959","article-title":"Effects of parathyroid hormone on renal tubular calcium and phosphate handling","volume":"238","author":"Alexander","year":"2023","journal-title":"Acta Physiol"},{"issue":"8","key":"2024110806311245900_ref18","doi-asserted-by":"publisher","first-page":"e99123","DOI":"10.1172\/jci.insight.99123","article-title":"Canagliflozin triggers the FGF23\/1,25-dihydroxyvitamin D\/PTH axis in healthy volunteers in a randomized crossover study","volume":"3","author":"Blau","year":"2018","journal-title":"JCI Insight"},{"issue":"8","key":"2024110806311245900_ref19","doi-asserted-by":"publisher","first-page":"e105638","DOI":"10.1371\/journal.pone.0105638","article-title":"Pharmacodynamic effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, from a randomized study in patients with type 2 diabetes","volume":"9","author":"Sha","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"2024110806311245900_ref20","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1007\/s12325-015-0234-0","article-title":"Pharmacokinetics, pharmacodynamics, and safety of canagliflozin in Japanese patients with type 2 diabetes mellitus","volume":"32","author":"Iijima","year":"2015","journal-title":"Adv Ther"},{"issue":"5","key":"2024110806311245900_ref21","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s11914-020-00609-z","article-title":"Diabetes and bone fragility: SGLT2 inhibitor use in the context of renal and cardiovascular benefits","volume":"18","author":"Jackson","year":"2020","journal-title":"Curr Osteoporos Rep"},{"issue":"3","key":"2024110806311245900_ref22","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1007\/s11357-023-00803-8","article-title":"Long-term effects of canagliflozin treatment on the skeleton of aged UM-HET3 mice","volume":"45","author":"Yildirim","year":"2023","journal-title":"GeroScience"},{"key":"2024110806311245900_ref23","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.bone.2015.07.025","article-title":"SGLT2 inhibitor therapy improves blood glucose but does not prevent diabetic bone disease in diabetic DBA\/2J male mice","volume":"82","author":"Thrailkill","year":"2016","journal-title":"Bone"},{"issue":"11","key":"2024110806311245900_ref24","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.1210\/en.2014-1452","article-title":"Igfbp2 deletion in ovariectomized mice enhances energy expenditure but accelerates bone loss","volume":"156","author":"DeMambro","year":"2015","journal-title":"Endocrinology"},{"issue":"2","key":"2024110806311245900_ref25","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1096\/fj.201800948RR","article-title":"Progenitor recruitment and adipogenic lipolysis contribute to the anabolic actions of parathyroid hormone on the skeleton","volume":"33","author":"Maridas","year":"2019","journal-title":"FASEB J"},{"issue":"7","key":"2024110806311245900_ref26","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro\u2013computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J Bone Miner Res"},{"key":"2024110806311245900_ref27","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.bone.2019.03.038","article-title":"Inverse correlation between trabecular bone volume and bone marrow adipose tissue in rats treated with osteoanabolic agents","volume":"123","author":"Costa","year":"2019","journal-title":"Bone"},{"issue":"24","key":"2024110806311245900_ref28","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"},{"key":"2024110806311245900_ref29","doi-asserted-by":"publisher","first-page":"115254","DOI":"10.1016\/j.bone.2020.115254","article-title":"Genetic ablation of SGLT2 function in mice impairs tissue mineral density but does not affect fracture resistance of bone","volume":"133","author":"Thrailkill","year":"2020","journal-title":"Bone"},{"issue":"4","key":"2024110806311245900_ref30","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00223-019-00652-8","article-title":"Age- and strain-related differences in bone microstructure and body composition during development in inbred male mouse strains","volume":"106","author":"Papageorgiou","year":"2020","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"2024110806311245900_ref31","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S8756-3282(97)00143-9","article-title":"Circulating and skeletal insulin-like growth factor-I (IGF-i) concentrations in two inbred strains of mice with different bone mineral densities","volume":"21","author":"Rosen","year":"1997","journal-title":"Bone"},{"issue":"8","key":"2024110806311245900_ref32","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1359\/jbmr.070507","article-title":"Age-related changes in trabecular architecture differ in female and male C57BL\/6J mice","volume":"22","author":"Glatt","year":"2007","journal-title":"J Bone Miner Res"},{"issue":"5","key":"2024110806311245900_ref33","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00223-003-0101-x","article-title":"Growth of C57Bl\/6 mice and the material and mechanical properties of cortical bone from the tibia","volume":"74","author":"Somerville","year":"2004","journal-title":"Calcif Tissue Int"},{"key":"2024110806311245900_ref34","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/B978-012369454-6\/50074-1","volume-title":"The Mouse in Biomedical Research, American College of Laboratory Animal Medicine","author":"Flurkey","year":"2007"},{"issue":"3","key":"2024110806311245900_ref35","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1023\/a:1011513223894","article-title":"Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis","volume":"2","author":"Justesen","year":"2001","journal-title":"Biogerontology"},{"issue":"1","key":"2024110806311245900_ref36","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/8756-3282(94)90893-1","article-title":"Age-related bone loss in mice is associated with an increased osteoclast progenitor pool","volume":"15","author":"Perkins","year":"1994","journal-title":"Bone"},{"issue":"1","key":"2024110806311245900_ref37","first-page":"45","article-title":"Age-related trend for osteopenia in femurs of female C57Bl\/6 mice","volume":"1","author":"Silbermann","year":"1987","journal-title":"Compr Gerontol [A]"},{"issue":"3","key":"2024110806311245900_ref38","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S8756-3282(03)00199-6","article-title":"Bone development and age-related bone loss in male C57BL\/6J mice","volume":"33","author":"Ferguson","year":"2003","journal-title":"Bone"},{"key":"2024110806311245900_ref39","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3389\/fendo.2016.00139","article-title":"Qualitative aspects of bone marrow adiposity in osteoporosis","volume":"7","author":"Pino","year":"2016","journal-title":"Front Endocrinol"},{"issue":"1","key":"2024110806311245900_ref40","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/jmri.23619","article-title":"Bone marrow fat content in the elderly: a reversal of sex difference seen in younger subjects","volume":"36","author":"Griffith","year":"2012","journal-title":"J Magn Reson Imaging"},{"issue":"8","key":"2024110806311245900_ref41","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqab079","article-title":"SGLT2 inhibitors as calorie restriction Mimetics: insights on longevity pathways and age-related diseases","volume":"162","author":"Hoong","year":"2021","journal-title":"Endocrinology"},{"issue":"9","key":"2024110806311245900_ref42","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1002\/jbmr.82","article-title":"Caloric restriction leads to high marrow adiposity and low bone mass in growing mice","volume":"25","author":"Devlin","year":"2010","journal-title":"J Bone Miner Res"},{"key":"2024110806311245900_ref43","doi-asserted-by":"publisher","first-page":"e69209","DOI":"10.7554\/eLife.69209","article-title":"Adipsin promotes bone marrow adiposity by priming mesenchymal stem cells","volume":"10","author":"Aaron","year":"2021","journal-title":"elife"},{"issue":"3","key":"2024110806311245900_ref44","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1089\/dia.2019.0372","article-title":"Canagliflozin increases calorie intake in type 2 diabetes without changing the energy ratio of the three macronutrients: CANA-K study","volume":"22","author":"Matsuba","year":"2020","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"2024110806311245900_ref45","doi-asserted-by":"publisher","first-page":"16004","DOI":"10.1038\/boneres.2016.4","article-title":"In vivo radiometric analysis of glucose uptake and distribution in mouse bone","volume":"4","author":"Zoch","year":"2016","journal-title":"Bone Res"},{"issue":"4","key":"2024110806311245900_ref46","doi-asserted-by":"publisher","first-page":"C1220","DOI":"10.1152\/ajpcell.2000.279.4.C1220","article-title":"Bioenergetics and mitochondrial transmembrane potential during differentiation of cultured osteoblasts","volume":"279","author":"Komarova","year":"2000","journal-title":"Am J Physiol-Cell Physiol"},{"issue":"5","key":"2024110806311245900_ref47","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1210\/en.2013-1974","article-title":"Bioenergetics during calvarial osteoblast differentiation reflect strain differences in bone mass","volume":"155","author":"Guntur","year":"2014","journal-title":"Endocrinology"},{"key":"2024110806311245900_ref48","doi-asserted-by":"publisher","first-page":"116257","DOI":"10.1016\/j.bone.2021.116257","article-title":"NAD(P)H autofluorescence lifetime imaging enables single cell analyses of cellular metabolism of osteoblasts in vitro and in vivo via two-photon microscopy","volume":"154","author":"Schilling","year":"2022","journal-title":"Bone"},{"issue":"7","key":"2024110806311245900_ref49","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1016\/j.cell.2015.05.029","article-title":"Glucose uptake and Runx2 synergize to orchestrate osteoblast differentiation and bone formation","volume":"161","author":"Wei","year":"2015","journal-title":"Cell"},{"issue":"1","key":"2024110806311245900_ref50","doi-asserted-by":"publisher","first-page":"21020","DOI":"10.1038\/s41598-020-77892-4","article-title":"Metabolic reprogramming of osteoclasts represents a therapeutic target during the treatment of osteoporosis","volume":"10","author":"Taubmann","year":"2020","journal-title":"Sci Rep"}],"container-title":["JBMR Plus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbmrplus\/advance-article-pdf\/doi\/10.1093\/jbmrpl\/ziae128\/59713878\/ziae128.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article-pdf\/8\/12\/ziae128\/60534089\/ziae128.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article-pdf\/8\/12\/ziae128\/60534089\/ziae128.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T01:31:47Z","timestamp":1731029507000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article\/doi\/10.1093\/jbmrpl\/ziae128\/7817836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,10]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,11,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jbmrpl\/ziae128","relation":{},"ISSN":["2473-4039"],"issn-type":[{"value":"2473-4039","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,12]]},"published":{"date-parts":[[2024,10,10]]},"article-number":"ziae128"}}